Trading Ideas Bristol-Myers Squibb Company Berne S.E.

Equities

End-of-day quote Berne S.E. Other stock markets 06:00:00 2024-06-20 pm EDT			5-day change	1st Jan Change
54.24 ^CHF	-.--%		-.--%	-.--%

03:37pm	UBS Cuts Bristol-Myers Squibb Price Target to $43 From $47, Maintains Neutral Rating	MT
Jul. 11	Redburn Atlantic Adjusts Price Target on Bristol-Myers Squibb to $50 From $54, Maintains Neutral Rating	MT

BRISTOL-MYERS SQUIBB COMPANY :The beginning of the move	19-09-18
BRISTOL-MYERS SQUIBB COMPANY :Underpinned by a support level	19-04-08
BRISTOL-MYERS SQUIBB COMPANY :Attractive price levels	16-09-26

No results for this search

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 01:06 pm EST